StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
FTRE

Fortrea Holdings Inc.

FTRE Nasdaq Services-Medical Laboratories EDGAR ↗
$18.94
-0.14 -0.73%

Key statistics

from XBRL data in SEC filings
Market cap
$1.80B
Revenue (TTM)
$2.68B
Net income (TTM)
-$88.0M
EPS (TTM)
$-0.81
P/E ratio
Dividend yield
Free cash flow
$88.3M
Cash
$169M
Total assets
$2.71B
Gross margin
52-week range
$5.82 – $21.39

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release); Director or officer change Jul 29, 2026 8-K Director or officer change Jul 14, 2026 8-K Director or officer change; Regulation FD disclosure Jun 26, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Nov 20, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change; Regulation FD disclosure Sep 22, 2025 8-K Director or officer change Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Jun 12, 2025 8-K Director or officer change; Regulation FD disclosure Jun 11, 2025 8-K/A Director or officer change May 15, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change; Regulation FD disclosure; Other events May 12, 2025 8-K Director or officer change Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Feb 21, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 8, 2024 8-K/A Director or officer change Aug 26, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Director or officer change; Regulation FD disclosure Jul 11, 2024 8-K Regulation FD disclosure Jun 20, 2024 8-K/A Regulation FD disclosure Jun 7, 2024 8-K Regulation FD disclosure Jun 4, 2024 8-K Regulation FD disclosure May 24, 2024 10-Q Quarter ended 2024-03-31 May 24, 2024 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure May 16, 2024 8-K Results of operations (earnings release) May 13, 2024